Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Casaubon who wrote (100434)	8/6/2009 2:35:23 AM
From: Elroy Jetson	4 Recommendations Read Replies (1) \| Respond to of 116555

You math conceptualization is off slightly. Big Pharma firms have earned a disproportionate return on capital, paid larger salaries and more salaries, and paid larger dividends than they could have otherwise done. As a result, their stocks have traditionally sold at a price which is triple what they might have otherwise. In recent years these stocks have sold off as smart investors have realized the U.S. economy can no longer afford to lavish special favors on this government protected fiefdom. It's inevitable that the gravy train large pharma firms have created through political influence returns to the discipline of the free market. .